JAK1 and JAK2 enzymes — Drug Target
All drugs that target JAK1 and JAK2 enzymes — marketed and clinical-stage. Includes 1 drug classes acting on this target.
Drug classes
Marketed (1)
- Chronic- PF-06480605 150 mg SC Q4W · Pfizer · Janus kinase inhibitor · Immunology